Vascular Embolization Market Research Report Information By Embolization Technique (Coiling Devices and Non-coiling Devices), By Application (Peripheral Vascular Disease, Oncology, Neurology, Urology, and Other), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Modality

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL VASCULAR EMBOLIZATION MARKET, BY EMBOLIZATION TECHNIQUE

6.1. Overview

6.2. Coiling Devices

6.3. Non-coiling Devices

7. GLOBAL VASCULAR EMBOLIZATION MARKET, BY APPLICATION

7.1. Overview

7.2. Peripheral Vascular Disease

7.3. Oncology

7.4. Neurology

7.5. Urology

7.6. Other

8. GLOBAL VASCULAR EMBOLIZATION MARKET, BY REGION

8.1. Overview

8.2. North America

8.2.1. U.S.

8.2.2. Canada

8.3. Europe

8.3.1. Germany

8.3.2. France

8.3.3. U.K

8.3.4. Italy

8.3.5. Spain

8.3.6. Rest of Europe

8.4. Asia-Pacific

8.4.1. China

8.4.2. India

8.4.3. Japan

8.4.4. South Korea

8.4.5. Australia

8.4.6. Rest of Asia-Pacific

8.5. Rest of the World

8.5.1. Middle East

8.5.2. Africa

8.5.3. Latin America

9. COMPETITIVE LANDSCAPE

9.1. Overview

9.2. Competitive Analysis

9.3. Market Share Analysis

9.4. Major Growth Strategy in the Global Vascular Embolization Market,

9.5. Competitive Benchmarking

9.6. Leading Players in Terms of Number of Developments in the Global Vascular Embolization Market,

9.7. Key developments and Growth Strategies

9.7.1. New EMBOLIZATION TECHNIQUE Launch/Application Deployment

9.7.2. Merger & Acquisitions

9.7.3. Joint Ventures

9.8. Major Players Financial Matrix

9.8.1. Sales & Operating Income, 2022

9.8.2. Major Players R&D Expenditure. 2022

10. COMPANY PROFILES

10.1. Shape Memory Medical Inc.

10.1.1. Company Overview

10.1.2. Financial Overview

10.1.3. Embolization Technique Offered

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. Terumo Corp

10.2.1. Company Overview

10.2.2. Financial Overview

10.2.3. Embolization Technique Offered

10.2.4. Key Developments

10.2.5. SWOT Analysis

10.2.6. Key Strategies

10.3. Abbott Laboratories

10.3.1. Company Overview

10.3.2. Financial Overview

10.3.3. Embolization Technique Offered

10.3.4. Key Developments

10.3.5. SWOT Analysis

10.3.6. Key Strategies

10.4. Stryker Corporation

10.4.1. Company Overview

10.4.2. Financial Overview

10.4.3. Embolization Technique Offered

10.4.4. Key Developments

10.4.5. SWOT Analysis

10.4.6. Key Strategies

10.5. Cook Medical

10.5.1. Company Overview

10.5.2. Financial Overview

10.5.3. Embolization Technique Offered

10.5.4. Key Developments

10.5.5. SWOT Analysis

10.5.6. Key Strategies

10.6. Medtronic PLC

10.6.1. Company Overview

10.6.2. Financial Overview

10.6.3. Embolization Technique Offered

10.6.4. Key Developments

10.6.5. SWOT Analysis

10.6.6. Key Strategies

10.7. Merit Medical Systems Inc.

10.7.1. Company Overview

10.7.2. Financial Overview

10.7.3. Embolization Technique Offered

10.7.4. Key Developments

10.7.5. SWOT Analysis

10.7.6. Key Strategies

10.8. Penumbra Inc.

10.8.1. Company Overview

10.8.2. Financial Overview

10.8.3. Embolization Technique Offered

10.8.4. Key Developments

10.8.5. SWOT Analysis

10.8.6. Key Strategies

10.9. Johnson and Johnson (Cerenovus)

10.9.1. Company Overview

10.9.2. Financial Overview

10.9.3. Embolization Technique Offered

10.9.4. Key Developments

10.9.5. SWOT Analysis

10.9.6. Key Strategies

10.10. Boston Scientific Corporation

10.10.1. Company Overview

10.10.2. Financial Overview

10.10.3. Embolization Technique Offered

10.10.4. Key Developments

10.10.5. SWOT Analysis

10.10.6. Key Strategies

11. APPENDIX

11.1. References

11.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL VASCULAR EMBOLIZATION MARKET, SYNOPSIS, 2018-2032

TABLE 2 GLOBAL VASCULAR EMBOLIZATION MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)

TABLE 3 GLOBAL VASCULAR EMBOLIZATION MARKET, BY EMBOLIZATION TECHNIQUE , 2018-2032 (USD BILLION)

TABLE 4 GLOBAL VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 5 NORTH AMERICA VASCULAR EMBOLIZATION MARKET, BY EMBOLIZATION TECHNIQUE , 2018-2032 (USD BILLION)

TABLE 6 NORTH AMERICA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 7 NORTH AMERICA VASCULAR EMBOLIZATION MARKET, BY COUNTRY, 2018-2032 (USD BILLION)

TABLE 8 U.S. VASCULAR EMBOLIZATION MARKET, BY EMBOLIZATION TECHNIQUE , 2018-2032 (USD BILLION)

TABLE 9 U.S. VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 10 CANADA VASCULAR EMBOLIZATION MARKET, BY EMBOLIZATION TECHNIQUE , 2018-2032 (USD BILLION)

TABLE 11 CANADA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 12 EUROPE VASCULAR EMBOLIZATION MARKET, BY EMBOLIZATION TECHNIQUE , 2018-2032 (USD BILLION)

TABLE 13 EUROPE VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 14 EUROPE VASCULAR EMBOLIZATION MARKET, BY COUNTRY, 2018-2032 (USD BILLION)

TABLE 15 GERMANY VASCULAR EMBOLIZATION MARKET, BY EMBOLIZATION TECHNIQUE , 2018-2032 (USD BILLION)

TABLE 16 GERMANY VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 17 FRANCE VASCULAR EMBOLIZATION MARKET, BY EMBOLIZATION TECHNIQUE , 2018-2032 (USD BILLION)

TABLE 18 FRANCE VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 19 ITALY VASCULAR EMBOLIZATION MARKET, BY EMBOLIZATION TECHNIQUE , 2018-2032 (USD BILLION)

TABLE 20 ITALY VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 21 SPAIN VASCULAR EMBOLIZATION MARKET, BY EMBOLIZATION TECHNIQUE , 2018-2032 (USD BILLION)

TABLE 22 SPAIN VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 23 U.K VASCULAR EMBOLIZATION MARKET, BY EMBOLIZATION TECHNIQUE , 2018-2032 (USD BILLION)

TABLE 24 U.K VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 25 REST OF EUROPE VASCULAR EMBOLIZATION MARKET, BY EMBOLIZATION TECHNIQUE , 2018-2032 (USD BILLION)

TABLE 26 REST OF EUROPE VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 27 ASIA PACIFIC VASCULAR EMBOLIZATION MARKET, BY EMBOLIZATION TECHNIQUE , 2018-2032 (USD BILLION)

TABLE 28 ASIA PACIFIC VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 29 ASIA PACIFIC VASCULAR EMBOLIZATION MARKET, BY COUNTRY, 2018-2032 (USD BILLION)

TABLE 30 JAPAN VASCULAR EMBOLIZATION MARKET, BY EMBOLIZATION TECHNIQUE , 2018-2032 (USD BILLION)

TABLE 31 JAPAN VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 32 CHINA VASCULAR EMBOLIZATION MARKET, BY EMBOLIZATION TECHNIQUE , 2018-2032 (USD BILLION)

TABLE 33 CHINA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 34 INDIA VASCULAR EMBOLIZATION MARKET, BY EMBOLIZATION TECHNIQUE , 2018-2032 (USD BILLION)

TABLE 35 INDIA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 36 AUSTRALIA VASCULAR EMBOLIZATION MARKET, BY EMBOLIZATION TECHNIQUE , 2018-2032 (USD BILLION)

TABLE 37 AUSTRALIA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 38 SOUTH KOREA VASCULAR EMBOLIZATION MARKET, BY EMBOLIZATION TECHNIQUE , 2018-2032 (USD BILLION)

TABLE 39 SOUTH KOREA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 40 REST OF ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET, BY EMBOLIZATION TECHNIQUE , 2018-2032 (USD BILLION)

TABLE 41 REST OF ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 42 REST OF WORLD VASCULAR EMBOLIZATION MARKET, BY EMBOLIZATION TECHNIQUE , 2018-2032 (USD BILLION)

TABLE 43 REST OF WORLD VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 44 REST OF WORLD VASCULAR EMBOLIZATION MARKET, BY COUNTRY, 2018-2032 (USD BILLION)

TABLE 45 MIDDLE EAST VASCULAR EMBOLIZATION MARKET, BY EMBOLIZATION TECHNIQUE , 2018-2032 (USD BILLION)

TABLE 46 MIDDLE EAST VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 47 AFRICA VASCULAR EMBOLIZATION MARKET, BY EMBOLIZATION TECHNIQUE , 2018-2032 (USD BILLION)

TABLE 48 AFRICA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 49 LATIN AMERICA VASCULAR EMBOLIZATION MARKET, BY EMBOLIZATION TECHNIQUE , 2018-2032 (USD BILLION)

TABLE 50 LATIN AMERICA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL VASCULAR EMBOLIZATION MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL VASCULAR EMBOLIZATION MARKET

FIGURE 4 GLOBAL VASCULAR EMBOLIZATION MARKET, SHARE (%), BY EMBOLIZATION TECHNIQUE , 2022

FIGURE 5 GLOBAL VASCULAR EMBOLIZATION MARKET, SHARE (%), BY APPLICATION, 2022

FIGURE 6 GLOBAL VASCULAR EMBOLIZATION MARKET, SHARE (%), BY REGION, 2022

FIGURE 7 NORTH AMERICA: VASCULAR EMBOLIZATION MARKET, SHARE (%), BY REGION, 2022

FIGURE 8 EUROPE: VASCULAR EMBOLIZATION MARKET, SHARE (%), BY REGION, 2022

FIGURE 9 ASIA-PACIFIC: VASCULAR EMBOLIZATION MARKET, SHARE (%), BY REGION, 2022

FIGURE 10 REST OF THE WORLD: VASCULAR EMBOLIZATION MARKET, SHARE (%), BY REGION, 2022

FIGURE 11 GLOBAL VASCULAR EMBOLIZATION MARKET: COMPANY SHARE ANALYSIS, 2022 (%)

FIGURE 12 SHAPE MEMORY MEDICAL INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 13 SHAPE MEMORY MEDICAL INC.: SWOT ANALYSIS

FIGURE 14 TERUMO CORP: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 15 TERUMO CORP: SWOT ANALYSIS

FIGURE 16 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 17 ABBOTT LABORATORIES: SWOT ANALYSIS

FIGURE 18 STRYKER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19 STRYKER CORPORATION: SWOT ANALYSIS

FIGURE 20 COOK MEDICAL.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 COOK MEDICAL.: SWOT ANALYSIS

FIGURE 22 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 MEDTRONIC PLC: SWOT ANALYSIS

FIGURE 24 MERIT MEDICAL SYSTEMS INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 MERIT MEDICAL SYSTEMS INC.: SWOT ANALYSIS

FIGURE 26 PENUMBRA INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 PENUMBRA INC.: SWOT ANALYSIS

FIGURE 28 JOHNSON AND JOHNSON (CERENOVUS): FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 JOHNSON AND JOHNSON (CERENOVUS): SWOT ANALYSIS

FIGURE 30 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS